367 related articles for article (PubMed ID: 20696500)
1. Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building.
Aboul-Fadl T; Bin-Jubair FA; Aboul-Wafa O
Eur J Med Chem; 2010 Oct; 45(10):4578-86. PubMed ID: 20696500
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophoric model building for antitubercular activity of the individual Schiff bases of small combinatorial library.
Abdel-Aal WS; Hassan HY; Aboul-Fadl T; Youssef AF
Eur J Med Chem; 2010 Mar; 45(3):1098-106. PubMed ID: 20045582
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Four hydrazide compounds that inhibit the growth of mycobacterium tuberculosis.
Bartzatt R; Cirillo SL; Cirillo JD
Physiol Chem Phys Med NMR; 2008; 40():55-65. PubMed ID: 20070040
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitubercular activity of novel Schiff bases derived from d-mannitol.
Ferreira Mde L; Vasconcelos TR; de Carvalho EM; Lourenço MC; Wardell SM; Wardell JL; Ferreira VF; de Souza MV
Carbohydr Res; 2009 Oct; 344(15):2042-7. PubMed ID: 19709650
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
De P; Koumba Yoya G; Constant P; Bedos-Belval F; Duran H; Saffon N; Daffé M; Baltas M
J Med Chem; 2011 Mar; 54(5):1449-61. PubMed ID: 21309577
[TBL] [Abstract][Full Text] [Related]
8. New Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Inhibitors, Nalidixic Acid Linked to Isatin Schiff Bases via Certain l-Amino Acid Bridges.
Naglah AM; Ahmed AF; Wen ZH; Al-Omar MA; Amr Ael-G; Kalmouch A
Molecules; 2016 Apr; 21(4):498. PubMed ID: 27092477
[TBL] [Abstract][Full Text] [Related]
9. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
[TBL] [Abstract][Full Text] [Related]
10. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives.
Lourenço MC; Ferreira Mde L; de Souza MV; Peralta MA; Vasconcelos TR; Henriques Md
Eur J Med Chem; 2008 Jun; 43(6):1344-7. PubMed ID: 17923172
[TBL] [Abstract][Full Text] [Related]
12. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of bis-Schiff bases of isatins and their antiglycation activity.
Khan KM; Khan M; Ali M; Taha M; Rasheed S; Perveen S; Choudhary MI
Bioorg Med Chem; 2009 Nov; 17(22):7795-801. PubMed ID: 19837595
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC
Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219
[TBL] [Abstract][Full Text] [Related]
15. Novel N'-benzylidene benzofuran-3-carbohydrazide derivatives as antitubercular and antifungal agents.
Telvekar VN; Belubbi A; Bairwa VK; Satardekar K
Bioorg Med Chem Lett; 2012 Mar; 22(6):2343-6. PubMed ID: 22365752
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
Xu Z; Zhang S; Song X; Qiang M; Lv Z
Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
[TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and in vitro anti-mycobacterial activities of homonuclear and heteronuclear bis-isatin derivatives.
Xu Y; Guan J; Xu Z; Zhao S
Fitoterapia; 2018 Jun; 127():383-386. PubMed ID: 29631015
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
